Interplay between miRNAs and human diseases

P Paul, A Chakraborty, D Sarkar… - Journal of cellular …, 2018 - Wiley Online Library
MicroRNAs (miRNAs) are endogenous, non‐coding RNAs, which have evoked a great deal
of interest due to their importance in many aspects of homeostasis and diseases …

Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives

W Poller, S Dimmeler, S Heymans, T Zeller… - European heart …, 2018 - academic.oup.com
Recent research has demonstrated that the non-coding genome plays a key role in genetic
programming and gene regulation during development as well as in health and …

[HTML][HTML] Application of the nano-drug delivery system in treatment of cardiovascular diseases

Y Deng, X Zhang, H Shen, Q He, Z Wu… - … in bioengineering and …, 2020 - frontiersin.org
Cardiovascular diseases (CVDs) have become a serious threat to human life and health.
Though many drugs acting via different mechanism of action are available in the market as …

Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets

YK Tham, BC Bernardo, JYY Ooi, KL Weeks… - Archives of …, 2015 - Springer
The onset of heart failure is typically preceded by cardiac hypertrophy, a response of the
heart to increased workload, a cardiac insult such as a heart attack or genetic mutation …

Therapeutic Cardiac‐Targeted Delivery of miR‐1 Reverses Pressure Overload–Induced Cardiac Hypertrophy and Attenuates Pathological Remodeling

I Karakikes, AH Chaanine, S Kang… - Journal of the …, 2013 - Am Heart Assoc
Background Micro RNA s (mi RNA s) play a key role in the development of heart failure, and
recent studies have shown that the muscle‐specific miR‐1 is a key regulator of cardiac …

Essential role for premature senescence of myofibroblasts in myocardial fibrosis

K Meyer, B Hodwin, D Ramanujam… - Journal of the American …, 2016 - jacc.org
Background: Fibrosis is a hallmark of many myocardial pathologies and contributes to
distorted organ architecture and function. Recent studies have identified premature …

[HTML][HTML] Altered myocardial calcium cycling and energetics in heart failure—a rational approach for disease treatment

PA Gorski, DK Ceholski, RJ Hajjar - Cell metabolism, 2015 - cell.com
Cardiomyocyte function depends on coordinated movements of calcium into and out of the
cell and the proper delivery of ATP to energy-utilizing enzymes. Defects in calcium-handling …

MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors

J Ganesan, D Ramanujam, Y Sassi, A Ahles… - Circulation, 2013 - Am Heart Assoc
Background—Several microRNAs (miRs) have been shown to regulate gene expression in
the heart, and dysregulation of their expression has been linked to cardiac disease. miR-378 …

Structural insight into the unique properties of adeno-associated virus serotype 9

MA DiMattia, HJ Nam, K Van Vliet, M Mitchell… - Journal of …, 2012 - Am Soc Microbiol
Adeno-associated virus serotype 9 (AAV9) has enhanced capsid-associated tropism for
cardiac muscle and the ability to cross the blood-brain barrier compared to other AAV …

[HTML][HTML] Emerging roles of circRNAs in the pathological process of myocardial infarction

ZJ Wen, H Xin, YC Wang, HW Liu, YY Gao… - … Therapy-Nucleic Acids, 2021 - cell.com
Myocardial infarction (MI) is defined as cardiomyocyte death in a clinical context consistent
with ischemic insult. MI remains one of the leading causes of morbidity and mortality …